Skip to main content
. 2017 Oct 27;1(24):2138–2146. doi: 10.1182/bloodadvances.2017010819

Figure 3.

Figure 3.

Effect of age on survival outcomes for patients. (A) OS between etoposide users and nonusers among patients age <45 years old based on SNUH data. (B) PFS between etoposide users and nonusers among patients age <45 years based on SNUH data. (C) OS between etoposide users and nonusers among patients age ≥45 years based on SNUH data. (D) PFS between etoposide users and nonusers among patients age ≥45 years based on SNUH data. (E) OS between etoposide users and nonusers among patients age <45 years based on KCCR data. (F) PFS between etoposide users and nonusers among patients age <45 years based on KCCR data. (G) OS between etoposide users and nonusers among patients age ≥45 years based on KCCR data. (H) PFS between etoposide users and nonusers among patients age ≥45 years based on KCCR data.